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Epithelial cells are important in inflammation and immunity. In this study, we examined if Madin-Darby
canine kidney (MDCK) epithelial cells express functional P2X7 receptors, which bind the damageassociated molecular pattern extracellular adenosine 5'-triphosphate (ATP). Reverse transcription (RT)PCR and immunoblotting revealed the expression of P2X7 in MDCK cells. A flow cytometric assay
demonstrated that ATP or 2'(3')-O-(4-benzoylbenzoyl)ATP induced ethidium(+) uptake into MDCK cells,
and that this process was impaired by the P2X7 antagonists KN-62 and A438079. RT-PCR also
demonstrated the presence of Toll-like receptor 4, NALP3, caspase-1, interleukin-1β and interleukin-18 in
MDCK cells, as well as in positive control LPS-primed canine monocytes. In conclusion, the MDCK
epithelial cell line expresses functional P2X7, as well as Toll-like receptor 4 and molecules associated
with the NALP3 inflammasome. This cell line may help elucidate the role of these molecules in kidney
epithelial cells and renal disorders in dogs and humans.
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Abstract

Epithelial cells are important in inflammation and immunity. In this study, we examined if
Madin-Darby canine kidney (MDCK) epithelial cells express functional P2X7 receptors, which
bind the damage-associated molecular pattern extracellular adenosine 5’-triphosphate (ATP).
Reverse transcription (RT)-PCR and immunoblotting revealed the expression of P2X7 in
MDCK

cells.

A

flow

cytometric

assay

demonstrated

that

ATP

or

2′(3′)-O-(4-

benzoylbenzoyl)ATP induced ethidium+ uptake into MDCK cells, and that this process was
impaired by the P2X7 antagonists KN-62 and A438079. RT-PCR also demonstrated the
presence of Toll-like receptor 4, NALP3, caspase-1, interleukin-1β and interleukin-18 in
MDCK cells, as well as in positive control LPS-primed canine monocytes. In conclusion, the
MDCK epithelial cell line expresses functional P2X7, as well as Toll-like receptor 4 and
molecules associated with the NALP3 inflammasome. This cell line may help elucidate the role
of these molecules in kidney epithelial cells and renal disorders in dogs and humans.

Keywords: purinergic receptor; TLR4; inflammasome; cytokine; epithelial cell; dog

Abbreviations: ATP, adenosine 5’-triphosphate; BzATP, 2′(3′)-O-(4-benzoylbenzoyl)ATP;
DAMP, damage-associated molecular pattern; MDCK, Madin-Darby canine kidney; MFI, mean
fluorescence intensity; PAMP, pathogen-associated molecular pattern; RT, reverse
transcription; TLR4, Toll-like receptor 4.
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1. Introduction

Damage-associated molecular patterns (DAMPs) play important roles in inflammation
and immunity by functioning as signals of cell damage, stress or death during infection, injury
or disease (Kono and Rock, 2008; Chen and Nuñez, 2010). One of the best-characterized
DAMP is extracellular adenosine 5’-triphosphate (ATP) which mediates its effects through the
activation of purinergic receptors particularly P2X7, a trimeric ligand-gated cation channel
(Bours, et al., 2011; Wiley, et al., 2011). Activation of P2X7 by extracellular ATP or the most
potent P2X7 agonist 2′(3′)-O-(4-benzoylbenzoyl)ATP (BzATP) causes the flux of Ca2+, Na+ and
K+, as well as the uptake of organic cations such as ethidium+ (Jarvis and Khakh, 2009).
Furthermore, P2X7 activation induces various downstream events including the NALP3
inflammasome/caspase-1-dependent maturation of IL-1β and IL-18, and their subsequent
release from various myeloid cell types (Di Virgilio, 2007). This event, at least in monocytes,
requires the prior activation of cells with the Toll-like receptor 4 (TLR4) ligand, LPS, a wellcharacterized pathogen-associated molecular pattern that induces the up-regulation and
assembly of the NALP3 inflammasome, as well as the synthesis of IL-1β and IL-18 (Mehta, et
al., 2001; Bauernfeind, et al., 2009).
The role of P2X7 in inflammation and immunity is largely attributed to its expression on
myeloid and lymphoid cells, but there is emerging evidence that P2X7 on epithelial cells is
also involved in these responses. P2X7 activation prevents chlamydial infection in cervical
epithelial cells (Darville, et al., 2007), while kidney epithelial P2X7 is involved in inflammation
and renal injury (Goncalves, et al., 2006; Taylor, et al., 2009). Moreover, P2X7 activation
induces caspase-1-dependent IL-1β release from intestinal epithelial cells, implicating a role
for the NALP3 inflammasome in this process (Cesaro, et al., 2010). As a result of these and
other observations, P2X7 is attracting considerable interest as a therapeutic target in kidney
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and other disorders (Arulkumaran, et al., 2011). The role of P2X7 on epithelial cells from the
kidney and other tissues however remains poorly understood.
The presence of functional P2X7 on human and rodent cell types is well established, but
little is known about P2X7 in other mammalian species. We have previously demonstrated
that peripheral blood monocytes, lymphocytes and erythrocytes from English Springer
Spaniels and other breeds express functional P2X7 (Sluyter, et al., 2007; Shemon, et al., 2008;
Stevenson, et al., 2009; Jalilian, et al., 2012), however similar studies in other canine cell types
are lacking. Given the importance of P2X7 in human health and disease (Sluyter and Stokes,
2011), new knowledge about this receptor in the dog is necessary to establish and understand
the role of P2X7 in canine heath and disease.
Therefore, using molecular, immunochemical and pharmacological approaches we
investigated whether the Madin-Darby canine kidney (MDCK) epithelial cell line, originally
derived from a Cocker Spaniel, expresses functional P2X7 receptors. Moreover, we
investigated whether this cell line also expresses TLR4 and molecules associated with the
NALP3 inflammasome.

2. Materials and methods

2.1. Materials

RPMI-1640 medium, L-glutamine and ExoSAP-IT were from Invitrogen (Grand Island,
NJ). FCS was from Bovogen Biological (East Keilor, Australia). Ficoll-PaqueTM PLUS was from
GE Healthcare Biosciences (Uppsala, Sweden). Ethidium bromide was from Amresco (Solon,
OH). BigDye Terminator v3.1 was from Applied Biosystems (Carlsbad, CA). ATP, BzATP, LPS
(Escherichia Coli serotype 055:B5) and nigericin were from Sigma Chemical Co (St Louis, MO).
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KN-62 and A438079 were from Alexis Biochemicals (Lausen, Switzerland) and Tocris
Bioscience (Ellisville, MO), respectively.

2.2. Cells

MDCK (European Collection of Cell Cultures, Porton Down, UK) and RAW264.7
(American Type Culture Collection, Rockville, MD) cells were maintained in complete culture
medium (RPMI-1640 medium containing 2 mM L-glutamine and 10% FCS) at 37oC/5% CO2.
For PBMC isolation, peripheral blood was collected into VACUETTE® lithium heparin tubes
(Greiner Bio-One, Frickenheisen, Germany) from either pedigree or crossed breed dogs with
informed, signed consent of pet owners, and with the approval of the University of
Wollongong Ethics Committee (Wollongong, Australia). PBMCs were then isolated from buffy
coats using Ficoll-PaqueTM density centrifugation. PBMCs in complete culture medium were
then incubated for 2 h at 37oC/5% CO2, the non-adherent cells were removed by gently
washing twice with PBS, and the plastic-adherent cells incubated for a further 4 h in complete
culture medium containing 0.1 μg/ml LPS.

2.3. Detection of mRNA and protein

Total RNA was isolated using the RNeasy® Mini Kit (Qiagen, Hilden, Germany)
according to the manufacturer's instructions. Equal amounts of RNA for each cell type were
amplified by reverse transcription (RT)-PCR using the MyTaq™ One-Step RT-PCR Kit (Bioline,
Sydney Australia) according to the manufacturer’s instructions using primer pairs
(GeneWorks, Hindmarsh, Australia) specific for various canine mRNA transcripts (Table 1).
The identity of each transcript was confirmed by sequencing of Exo-SAP-IT purified

5

amplicons using the above primer pairs with BigDye Terminator and an Applied Biosystems
3130xl Genetic Analyzer.
Equal amounts of protein for whole cell lysates were separated by SDS-PAGE,
transferred to nitrocellulose membrane and immunoblotting was performed using a rabbit
anti-mouse P2X7 polyclonal Ab (Alomone Labs, Jerusalem, Israel) as described
(Constantinescu, et al., 2010). Mean fluorescence intensity (MFI) of cell-surface TLR4
expression was detected using PE-conjugated murine anti-human TLR4 (clone HTA125) and
IgG2a isotype mAbs (both eBioscience, San Diego, CA) and flow cytometry as described
(Gadeock, et al., 2010).

2.4. Ethidium+ uptake

Nucleotide-induced ethidium+ uptake into cells suspended in either sucrose (280 mM
sucrose, 5 mM KCl, 10 mM N-methyl-D-glucamine, 10 mM glucose, 0.1% BSA, 10 mM HEPES,
pH 7.4) or NaCl (145 mM NaCl, 5 mM KCl, 5 mM glucose, 0.1% BSA, 10 mM HEPES, pH 7.4)
medium was determined using a fixed-time flow cytometric assay as described (Gadeock, et
al., 2012).

2.5. IL-1β release

MDCK cells were incubated overnight in 24-well plates (2 x 105 cells/0.5 ml/well) at
37oC/5% CO2, and then in the absence or presence of LPS (as indicated) for 24 h.
Alternatively, MDCK cells were incubated overnight in 24-well plates (1 x 105 cells/well) at
37oC/5% CO2 and then in the absence or presence of 10 μg/ml LPS for 4 or 24 h. These cells
were then pre-incubated in RPMI-1640 medium (containing 0.1% bovine serum albumin) or
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in sucrose medium (containing 2 mM Ca2+ and 1 mM Mg2+) (0.3 ml/well) at 37oC/5% CO2 for
15 min, followed by 60 min incubation in the absence or presence of 3 or 5 mM ATP or 20 μM
nigericin. Following incubations, samples were centrifuged (11,000 x g for 30 s) and cell-free
supernatants stored at -80oC until required. The amount of IL-1β in cell-free supernatants was
quantified using a Canine IL-1β VetSetTM ELISA Development Kit Kingfisher Biotech (St. Paul,
MN) according to the manufacturer's instructions.

2.6. Statistical analysis

Quantitative data are presented as mean ± SD. Differences between treatments were
compared using ANOVA for multiple comparisons (with Tukey's post test).

3. Results and discussion

3.1. MDCK cells express functional P2X7 receptors

RT-PCR was first used to determine if MDCK cells express P2X7. Based on our recent
observations (Jalilian, et al., 2012), LPS-primed canine monocytes were used as a positive
control. Both MDCK cells and LPS-primed canine monocytes produced P2X7 mRNA (Fig. 1A).
Transcripts corresponded to the predicted size (240 bp) for P2X7 and sequencing confirmed
the identity of each as P2X7 (results not shown). Immunoblotting with a rabbit anti-murine
P2X7 Ab was then used to confirm the presence of P2X7 in MDCK cells. This Ab recognizes an
extracellular epitope of murine P2X7 (residues 132-152), which is 100% identical to the
corresponding sequence of canine P2X7. Murine RAW264.7 cells, which we have previously
shown to express P2X7 (Constantinescu, et al., 2010), were used as a positive control.
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Immunoblotting revealed the presence of a major band at 75 kDa, the predicted size of
glycosylated P2X7, in both MDCK and RAW264.7 cells (Fig. 1B).
Next we used a flow cytometric ethidium+ uptake assay to determine if MDCK cells
express functional P2X7. Preliminary experiments demonstrated that 5 min incubation of
MDCK cells suspended in NaCl medium with 1 mM ATP or 200 μM BzATP, the most potent
P2X7 agonist (Jarvis and Khakh, 2009), failed to induce ethidium+ uptake into these cells,
despite significant ethidium+ uptake into RAW264.7 cells in NaCl medium after 5 min ATP or
BzATP incubation (results not shown). Sucrose medium facilitates P2X7-induced cation
uptake in other cell types (Michel, et al., 1999; Gadeock, et al., 2012). Therefore, the ability of
ATP and BzATP to induce ethidium+ uptake into MDCK cells suspended in sucrose medium
was assessed. Both 1 mM ATP and 200 μM BzATP induced significant ethidium+ uptake into
MDCK cells within 5 min, as well as at later time-points (Fig. 1C). To determine whether the
ATP-induced ethidium+ uptake into MDCK cells was mediated by P2X7, cells suspended in
sucrose medium were pre-incubated in the absence or presence of the P2X7 antagonists, KN62 and A438079, which impair human, monkey, and murine P2X7 (Donnelly-Roberts, et al.,
2009; Bradley, et al., 2011). Pre-incubation of cells with 1 μM KN-62 or 10 μM A438079
inhibited 1 mM ATP-induced ethidium+ uptake by approximately 60% and 92%, respectively
(Fig. 1D). In contrast, KN-62 or A438079 did not significantly affect ethidium+ uptake in the
absence of ATP (Fig. 1D).
Collectively, the above results demonstrate that the MDCK epithelial cell line expresses
functional P2X7 receptors. The expression of P2X7 in MDCK cells however is relatively low,
with functional responses only observed in sucrose medium, a medium known to potentiate
P2X7-mediated responses (Michel, et al., 1999; Gadeock, et al., 2012). MDCK cells express
various P2Y purinergic receptors (Insel, et al., 2001), however to the best of our knowledge
the current study is the first to demonstrate the expression of any P2X purinergic receptor in
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these cells. The presence of P2X7, albeit at relatively low amounts, in MDCK cells indicates
caution should be exercised when studying these cells following transfection with
recombinant P2X7.
The low amount of P2X7 expression in MDCK epithelial cells is consistent with the low
to negligible amounts of P2X7 detected in human and murine kidney epithelium (Turner, et
al., 2007). Kidney epithelial P2X7 however is up-regulated in various renal disease states
including unilateral ureteral obstruction (Goncalves, et al., 2006) and glomerulonephritis
(Turner, et al., 2007). These studies indicate a potential pro-inflammatory or pro-apoptotic
role for P2X7 in these conditions. Although differences exist between established cell lines
and primary cells, the identification of P2X7 in MDCK cells suggests that these cells may serve
as a potential model to further investigate P2X7 in kidney epithelial physiology and
pathophysiology. It remains to be determined if the relative amount of P2X7 on MDCK cells is
altered by time post-seeding or inflammatory stimuli.

3.2. MDCK cells express TLR4, as well as molecules associated with the NALP3 inflammasome

NALP3 inflammasome activation, and the subsequent maturation and release of IL-1β
and IL-18 from LPS-primed monocytes are well-described events downstream of P2X7
activation (Di Virgilio, 2007). Therefore, RT-PCR was used to determine if MDCK cells express
TLR4, as well as the NALP3 inflammasome-associated molecules, NALP3, caspase-1, IL-1β and
IL-18. Both MDCK cells and LPS-primed canine monocytes produced TLR4, NALP3, caspase-1,
IL-1β and IL-18 mRNA (Fig. 2A), with transcripts corresponding to the predicted size (Table
1) for each molecule (results not shown). The identity of each transcript, with the exception of
IL-1β due to its small size of 64 bp, was also confirmed by sequencing (results not shown).
Immunolabeling with a murine anti-human TLR4 mAb, which detects canine TLR4
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(Burgener and Jungi, 2008), and flow cytometry was used to confirm the presence of TLR4 in
MDCK cells. Flow cytometric analysis demonstrated cell-surface TLR4 expression on MDCK
cells with a MFI of 11.1 ± 0.9 (n=3) (Fig. 2B). Previous studies have shown that MDCK cells
express TLR4 (Sun, et al., 2007), while incubation with LPS can induce Erk1/2
phosphorylation in these cells (Liévin-Le Moal, et al., 2011). Collectively, the current and
previous studies demonstrate that the MDCK epithelial cell line express functional TLR4.
TLR4 has an emerging role in renal disease. In particular, TLR4 activation induces proinflammatory cytokine and chemokine expression in kidney epithelial cells, and plays a
significant role in the inflammation and associated damage in kidney ischemia/reperfusion
injury (Wu, et al., 2007). Given that DAMPS, such as HMGB1, biglycan and hyaluronan, can
also activate TLR4 and are released during renal ischemia/reperfusion injury (Wu, et al.,
2007) it will be of interest to see if these DAMPs can stimulate TLR4 on MDCK cells.
The above results also demonstrate that MDCK cells express NALP3, caspase-1, IL-1β
and IL-18 mRNA. To the best of our knowledge the expression of NALP3, caspase-1 and IL-18
have not been directly observed in MDCK cells, although pharmacological blockade of
caspase-1 prevents apoptosis in MDCK cells (Feldenberg, et al., 1999) indirectly supporting
the presence of this enzyme in these cells. In contrast, IL-1β mRNA has been previously
demonstrated in MDCK cells (Gröne, et al., 2002). Despite various attempts however we were
unable to detect IL-1β in cell-free supernatants from MDCK cells using a commercially
available IL-1β ELISA kit (minimum assay sensitivity of 0.053 ng/ml). IL-1β was not detected
in supernatants from MDCK cells following 24 h incubation, while 24 h incubation of MDCK
cells with 0.1-10 μg/ml LPS also failed to induce detectable IL-1β release (results not shown).
Moreover, neither 60 min incubation with 3 mM ATP, 5 mM ATP nor 20 μM nigericin could
induce detectable IL-1β release from MDCK cells primed with 10 μg/ml LPS for 4 or 24 h, or
from unprimed MDCK cells (results not shown). This result contrasts our recent observations
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with LPS-primed canine monocytes, in which 30 min incubation with 5 mM ATP induced IL1β release (Jalilian, et al., 2012). The inability of ATP to induce IL-1β from MDCK cells could
not be solely attributed to the low amount of P2X7 on MDCK cells, as nigericin, which induces
IL-1β release independently of P2X7 activation (Solle, et al., 2001; Sluyter, et al., 2004), also
failed to induce IL-1β from MDCK cells. Thus, it is likely that IL-1β and/or other NALP3
inflammasome-associated molecules are present at low amounts in MDCK cells, and that the
LPS-priming conditions employed in this study are insufficient to activate or up-regulate
these molecules to cause detectable IL-1β release.
The presence of NALP3 in MDCK cells is noteworthy. Recent evidence using knockout
mice indicates that kidney epithelial-expressed NALP3, independently of inflammasome
activation and cytokine release, mediates the inflammation and associated tissue damage
during renal ischemia/reperfusion injury (Shigeoka, et al., 2010). Whether the autocrine
release of ATP and subsequent activation of P2X7 is involved in this process in vivo remains
unknown, however MDCK cells can release ATP following mechanical stimulation (Ostrom, et
al., 2000), and thus may serve as a suitable model cell line to study this potential mechanism
further.

3.3. Conclusion

In conclusion, this study demonstrates that the MDCK epithelial cell line express
functional P2X7, as well as TLR4 and molecules associated with the NALP3 inflammasome,
and suggests that this cell line will be useful for determining the role of these molecules in
kidney epithelial physiology and pathophysiology. Moreover, further studies using healthy
and diseased kidney tissue from dogs are warranted to further investigate the role of these
receptors in canine renal disorders.
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Figure legends

Fig. 1. MDCK cells express functional P2X7 receptors. (A) RNA, isolated from MDCK cells and
LPS-primed canine monocytes, was amplified by RT-PCR using P2X7 specific primers and the
products examined by agarose gel electrophoresis. H2O in place of RNA was used as a negative
control. (B) Whole cell lysates from MDCK and RAW264.7 cells were separated by SDS-PAGE,
transferred to nitrocellulose membrane and probed with anti-P2X7 Ab. (C) MDCK in sucrose
medium were incubated with 25 μM ethidium+ in the absence or presence of 1 mM ATP or
200 μM BzATP at 37oC for up to 30 min (as indicated). (D) MDCK in sucrose medium were
pre-incubated with DMSO or 1 μM KN-62 (left panel), or in the absence (Control) or presence
of 10 μM A438079 (right panel) at 37oC for 15 min. Cells were then incubated with 25 μM
ethidium+ in the absence (Basal) or presence of 1 mM ATP at 37oC for 20 min. (C,D)
Incubations were stopped by MgCl2 solution and centrifugation, and the MFI of ethidium+
uptake measured by flow cytometry. Results are mean ± SD (n=3); *P<0.05 compared to
corresponding basal, †P<0.05 compared to corresponding ATP alone.

Fig. 2. MDCK cells express TLR4, as well as molecules associated with the NALP3
inflammasome. (A) RNA, isolated from MDCK cells and LPS-primed canine monocytes, was
amplified by RT-PCR using primers specific for various mRNA transcripts (as indicated) and
the products examined by agarose gel electrophoresis. H2O in place of RNA was used as a
negative control and demonstrated no products (results not shown). (B) MDCK cells were
labeled with PE-conjugated TLR4 (solid line) or isotype control (shaded) mAb, and the relative
cell-surface TLR4 expression measured by flow cytometry.
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Figure 1

Figure 2

Table 1

Table 1 Primers and conditions for RT-PCR
Primera

Forward primer 5’-3’

Reverse primer 5’-3’

Cycle conditionsb

Product

Reference

size (bp)
P2X7

TGCCTCCCATCCCAGCTCCC

GTCCTGGGAGCCAAAGCGCC

95°C for 10 s, 62°C
240
for 10 s, 72°C for 30 s
TLR4
GTCTGGCTGGCTTAAAGATC
CTGCAATCTAGGATCTGGAG
95°C for 20 s, 52.4°C
910
for 20 s, 72°C for 60 s
NALP3
CACTGTCAGCCTTTGGCAGGGT
GTCTCCCAGGGCGTTGTGGC
95°C for 10 s, 63.7°C
273
for 10 s, 72°C for 30 s
Caspase-1 ACAGACGCTGGGGCTCTCCT
CCCAGGCCCTCCAGCAGACT
95°C for 10 s, 63.7°C
339
for 10 s, 72°C for 30 s
IL-1β
TGCAAAACAGATGCGGATAA
GTAACTTGCAGTCCACCGATT
95°C for 10 s, 53°C
64
for 10 s, 72°C for 30 s
IL-18
CCTGGAATCAGATTACTTTGGC
GTTTTGTTCTTACAGGAGAGAG 95°C for 10 s, 57°C
251
for 10 s, 72°C for 30 s
β-Actin
TGACCCAGATCATGTTTGAGACC TCCTGCTTGCTGATCCACATCT 95°C for 20 s, 63.6°C
700
for 20 s, 72° for 60 s
aPrimers
were designed from the corresponding sequences (http://www.ncbi.nlm.nih.gov/gene)

NM_001113456.1a
(Asahina, et al., 2003)
XM_843284.2a
NM_001003125.1a
(Maccoux, et al., 2007)
(Chamizo, et al., 2001)
(Swerdlow, et al.,
2006)
using Primer 3

(http://frodo.wi.mit.edu/primer3/).
bPCR

mixtures were incubated at 45°C for 20 min (except TLR4 and β-actin, 30 and 25 min, respectively), then at 95°C for 60 s, followed

by 42 cycles as indicated, and then a final extension at 72°C for 5 min.

